Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Pharmaceuticals & Biotech
/
Merck
MRK
Merck
I value it at $131
GI
Gil96
Not Invested
Community Contributor
Published
05 Mar 25
Updated
09 Jul 25
1
Set Fair Value
0
votes
Share
Gil96
's Fair Value
US$95.00
15.1% undervalued
intrinsic discount
09 Jul
US$80.69
Loading
1Y
-29.6%
7D
1.8%
Author's Valuation
US$95.0
15.1% undervalued
intrinsic discount
Gil96's Fair Value
View Valuation
Narrative
Updates
1
Shared on
09 Jul 25
Fair value Decreased 27%
Read more
0
votes
Share
Valuator
Company Info
Notes
Gil96
's
Fair Value
US$95.0
15.1% undervalued
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
0
84b
2014
2017
2020
2023
2025
2026
2029
2030
Revenue US$84.4b
Earnings US$22.5b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
2.97%
Pharma revenue growth rate
1.01%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$22.52b
Earnings '30
x
13.66x
PE Ratio '30
=
US$307.60b
Market Cap '30
US$307.60b
Market Cap '30
/
2.40b
No. shares '30
=
US$128.41
Share Price '30
US$128.41
Share Price '30
Discounted to 2025 @ 6.21% p.a.
=
US$94.99
Fair Value '25
